R-type calcium channels, denoted as CaV2.3, play a crucial role in neurotransmitter release at presynaptic terminals in the central nervous system. The R-type Ca++ CP α1E inhibitors are a specific class of chemical compounds designed to modulate these channels by selectively binding to the α1E subunit. The α1E subunit is a key component of the R-type calcium channel, and its inhibition results in the blockade of calcium influx into neurons. These inhibitors exhibit high selectivity for the α1E subunit, distinguishing them from other classes of calcium channel inhibitors. The specificity of these compounds is paramount in understanding their potential impact on neuronal function.
Structurally, R-type Ca++ CP α1E inhibitors often feature distinct chemical moieties that interact with specific binding sites on the α1E subunit, preventing its normal function. This class of inhibitors represents a targeted approach in the manipulation of calcium signaling within neurons, with potential implications for the modulation of synaptic transmission and neuronal excitability. By selectively inhibiting the R-type calcium channels, these compounds hold promise in unraveling the intricate mechanisms underlying neurotransmission, paving the way for a deeper understanding of neuronal physiology. The chemical design and structural specificity of R-type Ca++ CP α1E inhibitors underscore their importance as valuable tools for probing the intricacies of calcium-dependent processes in the nervous system, offering insights into potential avenues for further research in the field of neurobiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Blocks voltage-gated L-type and R-type calcium channels, reducing calcium influx into the cell. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Benzothiazepine that inhibits both L-type and R-type calcium channels, altering electrical conduction. | ||||||
Ethosuximide | 77-67-8 | sc-211431 | 1 g | $300.00 | ||
Preferentially inhibits T-type calcium channels but can alter R-type channel function through modulation of overall calcium homeostasis. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $55.00 $179.00 $345.00 | 1 | |
Heavy metal that non-selectively blocks voltage-gated calcium channels, including R-type. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
Blocks multiple types of calcium channels, including R-type, and also affects sodium and potassium channels. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Although primarily a sodium channel inhibitor, it can modulate calcium channel activity including R-type. | ||||||
Flunarizine | 52468-60-7 | sc-337841 | 5 g | $560.00 | ||
Calcium channel blocker that can inhibit R-type calcium channels among others. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Dihydropyridine calcium channel blocker that primarily targets L-type but may affect R-type channels. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Another divalent cation that can inhibit various calcium channels non-selectively, including R-type. | ||||||